Compare BIO-TECHNE Corp (TECH) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs TJX Companies Inc — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while TJX Companies Inc trades at $156.2 (market cap $175.45B). The key difference: TJX Companies Inc is far larger — about 15.6× BIO-TECHNE Corp's market cap, and TJX Companies Inc pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| TECH | TJX | |
|---|---|---|
Market Cap | $11.24B | $175.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $72.29 | $168.41 |
52-Week Low | $43.31 | $132.62 |
Enterprise Value | $11.32B | $184.05B |
Dividend Yield | 0.44% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
TJX trades at $161.36, down 0.42% on the day, with strong technical momentum indicated by bullish moving averages and key support at $160. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.19 beating expectations of $1.02, and impressive profitability metrics including 61.25% ROE and 9.4% net margin. Revenue growth continues steadily from $48.5B in 2022 to $56.4B in 2025, with positive cash flow trends projected for 2026.
TJX presents a compelling growth story with strong analyst support (88% buy ratings) and a $181.80 consensus price target offering 12.7% upside. The discount retail model shows resilience amid economic uncertainty, though elevated valuation multiples (P/E 31.39) and competitive pressures represent key risks. Upcoming Q2 FY27 earnings on August 19, 2026 will be crucial for validating the growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
